There's no insurance requirement, no membership fee, and it's HSA/FSA eligible
the day that fits your schedule and allows you to rest if needed is optimal
Trial SUSTAIN-6 (Marso et al., NEJM 2016) Design Phase 3 / 104 weeks Population 3,297 adults with T2D at high CV risk Key result 26% MACE reduction (HR 0.74
Medication Options Two pathways
Retatrutide Peptide vs Tesamorelin: Mechanisms, Evidence, and UK Availability Retatrutide peptide vs tesamorelin is a comparison that arises frequently in discussions around metabolic medicine and body composition, yet the two compounds differ fundamentally in their mechanisms, clinical evidence, and regulatory status
Important contraception consideration: Tirzepatide delays gastric emptying and can reduce the absorption of oral contraceptives